Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 12, Issue 525, Pages eaay4860
Publisher
American Association for the Advancement of Science (AAAS)
Online
2020-01-09
DOI
10.1126/scitranslmed.aay4860
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GARP Dampens Cancer Immunity by Sustaining Function and Accumulation of Regulatory T Cells in the Colon
- (2019) Mohammad Salem et al. CANCER RESEARCH
- Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models
- (2019) Heng Sheng Sow et al. Cells
- TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
- (2018) Daniele V. F. Tauriello et al. NATURE
- SWISS-MODEL: homology modelling of protein structures and complexes
- (2018) Andrew Waterhouse et al. NUCLEIC ACIDS RESEARCH
- Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy
- (2018) Rajani Ravi et al. Nature Communications
- Compensation of Signal Spillover in Suspension and Imaging Mass Cytometry
- (2018) Stéphane Chevrier et al. Cell Systems
- Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
- (2018) Rikke B. Holmgaard et al. Journal for ImmunoTherapy of Cancer
- TGF-β in T Cell Biology: Implications for Cancer Immunotherapy
- (2018) Amina Dahmani et al. Cancers
- Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells
- (2018) Stéphanie Liénart et al. SCIENCE
- Cutting Edge: Active TGF-β1 Released from GARP/TGF-β1 Complexes on the Surface of Stimulated Human B Lymphocytes Increases Class-Switch Recombination and Production of IgA
- (2017) Olivier Dedobbeleer et al. JOURNAL OF IMMUNOLOGY
- Dabigatran reduces thrombin-induced platelet aggregation and activation in a dose-dependent manner
- (2017) Pernille Just Vinholt et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Dabigatran Potentiates Gemcitabine-Induced Growth Inhibition of Pancreatic Cancer in Mice
- (2017) Kun Shi et al. MOLECULAR MEDICINE
- Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8
- (2017) Julie Stockis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel bifunctional anti-PD-L1/TGF-β Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells
- (2017) Justin M. David et al. OncoImmunology
- Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy
- (2017) Masaki Terabe et al. OncoImmunology
- Surface Expression of TGFβ Docking Receptor GARP Promotes Oncogenesis and Immune Tolerance in Breast Cancer
- (2016) Alessandra Metelli et al. CANCER RESEARCH
- Perioperative changes in TGF-β1 levels predict the oncological outcome of cryoablation-receiving patients with localized prostate cancer
- (2016) Alexander Sheng-Shin Wang et al. CRYOBIOLOGY
- High platelet counts increase metastatic risk in huge hepatocellular carcinoma undergoing transarterial chemoembolization
- (2016) Tong-Chun Xue et al. HEPATOLOGY RESEARCH
- High-dimensional single-cell analysis reveals the immune signature of narcolepsy
- (2016) Felix J. Hartmann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting immunosuppression by Tregs with monoclonal antibodies against GARP
- (2016) Stéphanie Liénart et al. OncoImmunology
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasis
- (2015) Eric T Alexander et al. CANCER BIOLOGY & THERAPY
- FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data
- (2015) Sofie Van Gassen et al. CYTOMETRY PART A
- Role of TGFβ in regulation of the tumor microenvironment and drug delivery (Review)
- (2015) PANAGIOTIS PAPAGEORGIS et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- GP96 is a GARP chaperone and controls regulatory T cell functions
- (2015) Yongliang Zhang et al. JOURNAL OF CLINICAL INVESTIGATION
- The effect of dabigatran and rivaroxaban on platelet reactivity and inflammatory markers
- (2015) Noa Zemer-Wassercug et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Transforming Growth Factor Beta Family: Insight into the Role of Growth Factors in Regulation of Fracture Healing Biology and Potential Clinical Applications
- (2015) Łukasz A. Poniatowski et al. MEDIATORS OF INFLAMMATION
- Regulation of the Expression of GARP/Latent TGF- 1 Complexes on Mouse T Cells and Their Role in Regulatory T Cell and Th17 Differentiation
- (2013) J. P. Edwards et al. JOURNAL OF IMMUNOLOGY
- GARP Is Regulated by miRNAs and Controls Latent TGF-β1 Production by Human Regulatory T Cells
- (2013) Emilie Gauthy et al. PLoS One
- How good is automated protein docking?
- (2013) Dima Kozakov et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- The Molecular Chaperone gp96/GRP94 Interacts with Toll-like Receptors and Integrins via Its C-terminal Hydrophobic Domain
- (2012) Shuang Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- GARP regulates the bioavailability and activation of TGFβ
- (2012) Rui Wang et al. MOLECULAR BIOLOGY OF THE CELL
- Novel diagnostic biomarkers for prostate cancer
- (2012) Chikezie O. Madu et al. Journal of Cancer
- Direct thrombin inhibitors
- (2011) Catherine J. Lee et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Use of dabigatran etexilate to reduce breast cancer progression
- (2011) Karen DeFeo et al. CANCER BIOLOGY & THERAPY
- Resolving the identity myth: Key markers of functional CD4+FoxP3+ regulatory T cells
- (2011) Xin Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Latent TGF-β structure and activation
- (2011) Minlong Shi et al. NATURE
- Deadly allies: the fatal interplay between platelets and metastasizing cancer cells
- (2010) L. Erpenbeck et al. BLOOD
- Platelet-Derived Transforming Growth Factor- Down-Regulates NKG2D Thereby Inhibiting Natural Killer Cell Antitumor Reactivity
- (2009) H.-G. Kopp et al. CANCER RESEARCH
- Membrane protein GARP is a receptor for latent TGF-β on the surface of activated human Treg
- (2009) Julie Stockis et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
- (2009) Ethan M. Shevach IMMUNITY
- GARP (LRRC32) is essential for the surface expression of latent TGF- on platelets and activated FOXP3+ regulatory T cells
- (2009) D. Q. Tran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Roles of TGFβ in metastasis
- (2008) David Padua et al. CELL RESEARCH
- Thrombin generation, fibrin clot formation and hemostasis
- (2008) Alisa S. Wolberg et al. TRANSFUSION AND APHERESIS SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now